LAWMAKERS IN A PICKLE OVER AI HEALTHCARE REGULATIONS
Artificial intelligence is a game-changer in healthcare, with over 692 AI products already approved by the FDA and billions of dollars invested into the AI health sector. But with rapid advancements comes the need for equally rapid regulation – and right now, regulators and lawmakers are playing catch-up. The government is now racing to develop rules to ensure transparency and privacy in the tech-driven healthcare landscape.
AI is a dynamic technology, morphing and evolving over time, which poses a significant challenge for regulators. Unlike drugs, which have static chemistry, AI is a constantly changing entity. The development of legislation is further complicated by the potential for AI to carry inherent biases, potentially worsening existing healthcare disparities. For instance, AI systems have been shown to double-book appointments for patients of color, who are deemed less likely to show up for their visits.
The technology’s transformative potential must be weighed against the risks, however. For example, there have been instances of AI ‘making things up’ – with a powerful chatbot fabricating claims in a convincing manner. In light of such challenges, policymakers find themselves in a bind as rapid advancements and continuous developments in AI require a forward-thinking and adaptable approach to regulation.
AI’s impact is here to stay, and it’s critical to regulate it effectively and fairly to ensure that patient outcomes are improved, not worsened. But let’s hear your thoughts! How do you think AI healthcare regulations should be approached? Let us know in the comments below!
IntelliPrompt curated this article: Read the full story at the original source by clicking here